Griffith University

Griffith academics appointed to 2019 ARC College of Experts

November 9th, 2018

Professor Vicky Avery is one of seven Griffith University academics to have been appointed as members of the 2019 ARC College of Experts. The full story can be found here.

Read more »

Griffith forms part of blockbuster deal with pharmaceutical giant

November 5th, 2018

Melbourne-based Cancer Therapeutics Co-operative Research Centre – which Griffith University is a foundation participant of – has struck a blockbuster research partnership with global pharmaceuticals giant Pfizer that could eventually be worth as much as $US460 million ($650 million). Full details found here.

Read more »

McCullough Robertson LSQ Industry Excellence Award

October 29th, 2018

Congratulations to Professor Vicky Avery who was awarded the McCullough Robertson Life Sciences QLD Industry Excellence award at the The Life Sciences Queensland Globally Engaging Networking Event (GENE) on Friday 26 October in Brisbane. This award is “presented to an individual that has made significant contributions to the performance and success of the Queensland Life Sciences Industry and will have demonstrated a breadth of impact across the sector.”

Read more »

Cancer Therapeutics CRC signs agreement with Pfizer

October 26th, 2018

Cancer Therapeutics CRC (CTx) today announced a two-year research collaboration and a license agreement with Pfizer Inc. (NYSE: PFE). Under the terms of the agreement, Pfizer will gain the rights to two novel pre-clinical cancer programs and CTx will receive US$14.2 million [AUD$20M] upfront payment, up to a potential US$460 million [AUD$648M] in development and sales milestones, as well as royalties on product sales if the program reaches commercialization. Find the full story here.    

Read more »

DNDi 10th Anniversary Meeting

October 19th, 2018
Read more »